Cortical Spreading Depolarization After Severe Traumatic Brain Injury

February 27, 2024 updated by: Samuel Cramer, Hennepin County Medical Center, Minneapolis
Preliminary evaluation of electrodes placed on the brain for recording brain activity and novel algorithms to determine cortical spreading depolarization foci of origination following severe traumatic brain injury requiring neurosurgical intervention.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The goal of this study is to improve our understanding of cortical spreading depolarizations (CSDs) as a mechanism of secondary injury in severe traumatic brain injury (TBI). The primary obstacles to advancing treatment of TBI are its heterogeneity in terms of cause, severity, pathophysiology and the paucity of therapeutic targets. At the current time, there is no intervention to reverse or restore the function of brain tissue damaged or lost during the initial traumatic insult; therefore the therapeutic focus is centered on minimizing secondary insults that result in expansion of the initial brain injury.

The past several years have witnessed significant advancement in the understanding of potential mechanisms of secondary injury after severe TBI. This is important work as secondary injury after severe TBI is thought to significantly increase the severity of the initial injury and this type of injury is thought to be open to interventions to attenuate the subsequent injury severity. Among the putative mechanisms of secondary injury after severe TBI, it was recently demonstrated that there is a relationship between CSD events and worse outcomes after severe TBI. Therefore, a more thorough understanding of the factors that influence the initiation and frequency of CSDs after TBI is warranted in order to develop therapeutic strategies to reduce or block these events from occurring.

In young people, TBI is the leading cause of morbidity and mortality in developed countries. TBI is a frequent sequelae of accidental injury in the USA with approximately 2.5 million people affected per year, approximately 10% of whom requiring extended hospitalization, often in an intensive care unit. Around 275,000 (15.1%) of hospital admissions and 52,000 deaths in the USA each year are due to TBI. Those that survive the initial insult invariably face prolonged stays in a neurologic intensive care unit (ICU), possible neurosurgical intervention, and prolonged period of post-acute supportive care. In the US, it is estimated that 5.3 million individuals are living with long-term disability as a result of TBI.

Given the complexity and duration of medical care that accompanies severe TBI, it follows that the cost of care associated with TBI are immense. It is estimated that total hospital charges for TBI-related admissions in 2010 were $21.4 billion. Beyond hospital charges, it is estimated that TBI costs the US economy $76.5 billion annually with the costs for disability and lost productivity outweighing those of acute medical care and rehabilitation.

Since their first description in 1944, spreading depolarizations (SDs) were subsequently demonstrated in numerous animal studies as a mechanism of secondary brain injury after ischemic stroke, subarachnoid hemorrhage (SAH), and traumatic brain injury. SDs have also been demonstrated to occur in the cerebral grey matter of the human brain in patients after acute brain injuries such as TBI, SAH, and ischemic stroke. To date, electrocorticography (ECoG) monitoring of over 500 patients after TBI has shown that SDs occur in 55-90% of individuals for days to weeks after the initial injury. These studies have demonstrated an initial peak in SD frequency at 1-2 days post-TBI and a second peak at 6-7 days. Furthermore, SDs are associated with worse outcomes after TBI.

SDs which consist of massive waves that depolarize neurons and astrocytes and disrupt local cortical function for minutes to hours, were first demonstrated to occur in severe TBI patients via ECoG recordings obtained from single subdural electrode strips. In these studies, severe TBI patients who underwent neurosurgical intervention for decompression and/or hematoma evacuation had a single linear subdural electrode strips (six electrodes with 10 mm spacing between electrodes) placed near the injury epicenter which allowed continuous ECoG recordings to be obtained for up to 7 days after the initial injury. The above studies, and several subsequent investigations, were important steps to demonstrate that (1) the SD phenomena, which was first described in animal studies, occurs in patients after TBI and (2) SDs are associated with worse outcome after TBI.

Despite the advances that have been made, previous studies discontinued ECoG recordings after a maximum of 7 days. A 7 day recording period is, however, likely inadequate to accurately characterize the total burden of SDs following TBI as previous work demonstrates an early peak period of SDs around 0-2 days post-TBI followed by a relative quiescent period and then a second peak of increased SD frequency around 7 days post-TBI. Therefore, a longer recordings period will provide a better understanding of the natural history of SDs following TBI and allow a more accurate understanding of the physiologic and pathophysiologic factors that influence initiation of these pathologic events.

All prior ECoG recordings of SDs has relied on subdural electrode strips consisting of a linear array of electrodes placed over the cerebral cortex near contused brain tissue. This recordings strategy is adequate to capture SD events, however, it affords the ability to monitor a small area of the cortical surface. The small monitoring area imposed several limitations on previous studies. First, CSDs are captured within a limited distance of each recording electrode contact. CSDs that occur beyond the monitoring region are not recorded and, therefore, prior studies likely underestimate the true frequency of SD events after TBI. Second, the linear configuration of subdural strips does not provide adequate spatial information regarding the CSD waves to determine the origin or direction of propagation. Improved spatial resolution of the ECoG recordings in conjunction with appropriate analytic techniques will allow determination of the direction of SD wave propagation and possibly the identification of pathologic foci where SDs originate. Identification of where SDs originate will afford the ability to correlate these locations with imaging to determine the structural characteristics and pathology that give rise to this pathological phenomenon.

The overall goal of this study is to preliminarily evaluate an improved recording strategy and analytical techniques to better define SD events and structural abnormalities in the severely injured brain that produce these CSD events in severe TBI. In order to achieve this goal, this study will utilize 4 subdural electrode strips arranged to produce a 4x4 grid of electrode contacts for the recording of ECoG activity in conjunction with simultaneous acquisition of several other physiological measures in TBI patients requiring neurosurgical intervention.

The findings of this study could provide a key advancement in the means to both monitor CSD events after TBI and identify the specific types of pathology that give rise to these events. This would be an important next step in the development of new interventions to reduce or eliminate the frequency of SDs in TBI patients and thus the degree of secondary brain injury that leads to greater morbidity and mortality after severe brain injury.

Despite advances that have been made in the care of patients after severe brain injury, TBI continues to confer a very high morbidity and mortality. The development of effective treatments to minimize the morbidity and mortality following TBI has been hindered due to a fundamental lack of understanding of the factors that contribute to secondary injury after the initial inciting traumatic event. By better understanding mechanisms of secondary brain injury after TBI, such as CSD, as well as methods for monitoring for pathologic events, there will be more opportunities to develop new treatments. This is a preliminary study with the goal of better characterizing CSD following severe TBI.

Subdural electrodes have been used extensively to record ECoG activity following TBI and other forms of brain injury. Despite requiring an invasive form of recording, ECoG activity remains the only established means to monitor CSD events. Invasive neuromonitoring via subdural electrodes was first demonstrated in the 1930s and continues to be a commonly performed neurosurgical procedure for epilepsy monitoring. A recent retrospective review found an overall complication rate of approximately 9.1% with 0.6% of patients experiencing permanent neurological deficits following subdural electrode placement.19 Furthermore, there has not been a single infection associated with subdural electrode placement at the University of Minnesota Medical Center. In addition to allowing detection of CSD events, subdural electrodes will allow the identification of subclinical seizures, and, therefore may provide a clinical benefit to the patients who undergo subdural electrode recording.

Subjects enrolled in this study will be selected from patients requiring neurosurgical intervention in the form of craniectomy or craniotomy and, therefore, will not be exposed to an invasive procedure solely for the placement of subdural recording electrodes. During the standard craniectomy/craniotomy procedure, the dura is opened to expose allowing the placement of the subdural recording strips with minimal modification to the standard surgical procedure. After the subdural strips are placed, the leads will be tunneled away from the brain so that they exit away from the brain, minimizing infection risk. This approach has the added benefit that when the study period is over, the tunneled leads can be removed at the bedside.

In addition to ECoG recordings, other forms of invasive neuromonitoring, including Licox bolt (Integra Life Sciences, Plainsboro, New Jersey) for measurement of ICP, brain tissue oxygenation and temperature, as well as external ventricular drain (EVD) will be placed as part of the current standard of care treatment for severe TBI.

The study period will be as long as invasive neuromonitoring is clinically indicated following severe TBI. As outlined in the background section, previous investigations of CSD have ended after a 7-day recording period. The shorter recording period has likely hindered a full understanding of the natural history of CSDs following severe TBI and therefore a full understanding of the pathophysiological factors that produce these events. There will be minimal additional risk to extending the recording period to the full period of clinically indicated invasive neuromonitoring as subdural recording is routinely performed at the University of Minnesota for epilepsy monitoring for 4-6 weeks without a documented serious complication.

Hennepin County Medical Center (HCMC) is a regional level 1 trauma center that serves the upper midwest and is one of the training sites for the University of Minnesota Neurosurgery Residency Program. As a large regional trauma center, there has historically been a large volume of severe TBI patients requiring neurosurgical intervention in the form of craniectomy or craniotomy with subsequent prolonged invasive neuromonitoring necessary as part of the clinical standard of care. The study population will be drawn from all trauma patients who present to the HCMC Emergency Department, trauma bay or as direct transfer to neurosurgery.

Study Type

Observational

Enrollment (Estimated)

10

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Samuel W Cramer, MD, PhD
  • Phone Number: 612-624-6666
  • Email: rnl@umn.edu

Study Contact Backup

  • Name: David P Darrow, MD, MPH
  • Phone Number: 612-624-6666
  • Email: rnl@umn.edu

Study Locations

  • United States
    • Minnesota
      • Minneapolis, Minnesota, United States, 55404
        • Recruiting
        • Hennepn Healthcare
        • Contact:
          • Samuel W Cramer, MD, PhD
          • Phone Number: 612-873-9113
          • Email: rnl@umn.edu
        • Contact:
          • David Darrow, MD, MPH
          • Phone Number: 612-624-6666

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients will be recruited from the population of severe TBI patients clinically judged to require neurosurgical intervention who present through the emergency department or upon direct transfer to the neurosurgery service at Hennepin County Medical Center. The target sample size for this preliminary study is 10 subjects.

Description

Inclusion Criteria:

  • Patient recommended to undergo craniectomy or craniotomy for the treatment of acute TBI

Exclusion Criteria:

  • Wound determined to be contaminated
  • Decompression is performed only in the posterior fossa
  • Known systemic infection
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Determination of foci that give rise to cortical spreading depolarizations
Time Frame: 2 years
2 years

Secondary Outcome Measures

Outcome Measure
Time Frame
Determine the relationship between cortical spreading depolarization foci of origination and structural pathology demonstrated on brain imaging (CT and MRI).
Time Frame: 2 years
2 years

Other Outcome Measures

Outcome Measure
Time Frame
Determine the association (if any) between cortical spreading depolarization foci of origination and cortical spreading depolarization frequency with relevant physiological data.
Time Frame: 2 years
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hennepin County Medical Center, Minneapolis

Investigators

  • Principal Investigator: Samuel W Cramer, MD, PhD, University of Minnesota Neurosurgery Department; Division of Neurosurgery, Department of Surgery, Hennepin County Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 14, 2019

Primary Completion (Estimated)

November 1, 2025

Study Completion (Estimated)

November 1, 2025

Study Registration Dates

First Submitted

October 22, 2017

First Submitted That Met QC Criteria

October 22, 2017

First Posted (Actual)

October 25, 2017

Study Record Updates

Last Update Posted (Actual)

February 28, 2024

Last Update Submitted That Met QC Criteria

February 27, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HSR 17-4400

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Deidentified, individual participant data that underlie the results reported in study publications (text, tables, figures, and appendices).

IPD Sharing Time Frame

Beginning 3 months and ending 36 months following article publication.

IPD Sharing Access Criteria

To investigators who provide a methodologically sound proposal whose proposed use of data has been approved by an independent review committee for the proposed purpose. Data requests should be directed to the corresponding author of the publication that forms the basis for the data requests. Investigators will have to sign a data use agreement in order to gain access to the data.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Traumatic Brain Injury

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe